Householder Group Estate & Retirement Specialist LLC Has $1.55 Million Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Householder Group Estate & Retirement Specialist LLC lowered its position in UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 1.3% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 2,936 shares of the healthcare conglomerate’s stock after selling 40 shares during the period. Householder Group Estate & Retirement Specialist LLC’s holdings in UnitedHealth Group were worth $1,545,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. Axiom Financial Strategies LLC bought a new position in shares of UnitedHealth Group in the 1st quarter valued at about $210,000. McGowan Group Asset Management Inc. grew its holdings in UnitedHealth Group by 8.9% during the 1st quarter. McGowan Group Asset Management Inc. now owns 744 shares of the healthcare conglomerate’s stock worth $379,000 after acquiring an additional 61 shares during the period. Mirae Asset Global Investments Co. Ltd. lifted its stake in shares of UnitedHealth Group by 31.8% in the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 250,196 shares of the healthcare conglomerate’s stock valued at $127,592,000 after purchasing an additional 60,300 shares during the period. MAS Advisors LLC grew its stake in shares of UnitedHealth Group by 10.8% during the first quarter. MAS Advisors LLC now owns 463 shares of the healthcare conglomerate’s stock worth $241,000 after purchasing an additional 45 shares during the period. Finally, First Western Trust Bank acquired a new position in UnitedHealth Group in the first quarter valued at about $875,000. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Stock Up 0.1 %

UNH stock opened at $458.51 on Wednesday. The company has a market cap of $422.71 billion, a price-to-earnings ratio of 19.22, a P/E/G ratio of 1.33 and a beta of 0.54. The company has a quick ratio of 0.79, a current ratio of 0.79 and a debt-to-equity ratio of 0.62. UnitedHealth Group Incorporated has a twelve month low of $445.68 and a twelve month high of $554.70. The business has a 50 day moving average price of $500.89 and a two-hundred day moving average price of $518.93.

UnitedHealth Group (NYSE:UNHGet Free Report) last announced its quarterly earnings results on Friday, January 12th. The healthcare conglomerate reported $6.16 EPS for the quarter, beating analysts’ consensus estimates of $5.98 by $0.18. The firm had revenue of $94.43 billion during the quarter, compared to analysts’ expectations of $92.13 billion. UnitedHealth Group had a net margin of 6.02% and a return on equity of 26.39%. The company’s revenue for the quarter was up 14.1% compared to the same quarter last year. During the same quarter last year, the company posted $5.34 earnings per share. Analysts anticipate that UnitedHealth Group Incorporated will post 27.82 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were paid a dividend of $1.88 per share. The ex-dividend date was Friday, March 8th. This represents a $7.52 annualized dividend and a dividend yield of 1.64%. UnitedHealth Group’s dividend payout ratio is currently 31.54%.

Wall Street Analyst Weigh In

Several research firms recently weighed in on UNH. HSBC reissued a “reduce” rating and set a $480.00 price objective (down previously from $550.00) on shares of UnitedHealth Group in a research note on Monday, December 18th. Bank of America reaffirmed a “buy” rating and set a $675.00 price objective on shares of UnitedHealth Group in a research note on Thursday, March 7th. Erste Group Bank restated a “hold” rating on shares of UnitedHealth Group in a report on Wednesday, March 13th. Cantor Fitzgerald reissued an “overweight” rating and set a $591.00 target price on shares of UnitedHealth Group in a research note on Friday, January 19th. Finally, Piper Sandler dropped their price objective on shares of UnitedHealth Group from $584.00 to $581.00 and set an “overweight” rating on the stock in a report on Wednesday, January 17th. One analyst has rated the stock with a sell rating, two have given a hold rating, fifteen have issued a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, UnitedHealth Group presently has a consensus rating of “Moderate Buy” and a consensus price target of $579.33.

Get Our Latest Stock Analysis on UnitedHealth Group

Insider Activity at UnitedHealth Group

In related news, CAO Thomas E. Roos sold 858 shares of UnitedHealth Group stock in a transaction dated Friday, February 23rd. The shares were sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the sale, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. In related news, CAO Thomas E. Roos sold 858 shares of the business’s stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the sale, the chief accounting officer now directly owns 32,289 shares in the company, valued at approximately $16,977,233.31. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Erin Mcsweeney sold 1,236 shares of UnitedHealth Group stock in a transaction on Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the sale, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at approximately $4,527,306.72. The disclosure for this sale can be found here. 0.35% of the stock is owned by company insiders.

UnitedHealth Group Company Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Further Reading

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.